DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Necon (Norethindrone / Mestranol) - Summary

 


Nutrilib.com
A comprihensive source of nutritional information

NECON SUMMARY

Necon ® 1/50 Tablets provide a continuous oral contraceptive regimen consisting of 21 white tablets containing norethindrone 1 mg and mestranol 0.05 mg and 7 orange tablets containing inert ingredients. Norethindrone is a potent progestational agent. Mestranol is an estrogen.

Oral contraceptives are indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception.

Oral contraceptive products such as Necon® 1/50, which contain 50 mcg of estrogen, should not be used unless medically indicated.


See all Necon indications & dosage >>

NECON NEWS HIGHLIGHTS

Media Articles Related to Necon (Norethindrone / Mestranol)

'Extended Cycle' Contraception Garners More Interest
Source: MedicineNet Birth Control Specialty [2008.08.25]

Male Contraception: Progress Slow but Steady
Source: MedicineNet Vasectomy Specialty [2008.04.14]

Increase In Unplanned Pregnancies, Abortions In Indian City Linked To Ban On Over-the-Counter EC Sales
Source: Abortion News From Medical News Today [2008.11.17]

more >>

Published Studies Related to Necon (Norethindrone / Mestranol)

Pharmacokinetics of three bioequivalent norethindrone/mestranol-50 micrograms and three norethindrone/ethinyl estradiol-35 micrograms OC formulations: are "low-dose" pills really lower? [1989.09]

more >>

Clinical Trials Related to Necon (Norethindrone / Mestranol)

TMC278-TiDP6-C136: Effect of TMC278 on Ethinylestradiol and Norethindrone in Healthy Women. [Recruiting]

Treatment of Hyperandrogenism vs. Insulin Resistance in Infertile PCOS Women [Not yet recruiting]

more >>

Page last updated: 2008-11-17

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008